Table 3.
Relative changes (%) in bone mineral density within groups and the between-group differences in the responses adjusted for baseline values and sex.
| PPa | IPa | PI | IP-PP | IP-PI | |
|---|---|---|---|---|---|
| Mean (SD) | Mean (95% CI) | ||||
| Lumbar spine | 1.3 (2.8) | 1.5 (2.5) | 0.9 (2.2) | 0.1 (−0.9, 1.2) | 0.5 (−0.5, 1.5) |
| Total hip | 0.5 (2.6) | 0.0 (1.9) | −0.3 (2.0) | −0.5 (−1.4, 0.4) | 0.3 (−0.6, 1.2) |
| Femoral neck | 0.2 (2.9) | 0.2 (2.8) | −0.1 (2.1) | 0.0 (−1.2, 1.1) | 0.2 (−0.9, 1.3) |
| Trochanter | 1.1 (3.1) | 0.0 (2.3) | −0.1 (2.7) | −1.1 (−2.3, 0.0) | 0.1 (−1.0, 1.2) |
| Sub-trochanter | 0.5 (3.4) | 0.0 (2.3) | −0.3 (2.5) | −0.6 (−1.8, 0.6) | 0.2 (−0.9, 1.4) |
a
3 participants had uninterpretable hip scans (1 placebo/placebo, 2 ibuprofen/placebo) and 2 participants had uninterpretable spine scans (2 ibuprofen/placebo).
PP, placebo before and placebo after exercise; IP, ibuprofen before and placebo after exercise; PI, placebo before and ibuprofen after exercise